AN UNBIASED VIEW OF AZELAPRAG BIOAGE

The biotech sought to bear this system out in STRIDES, a mid-stage, randomized, double-blinded and placebo-controlled trial that evaluated the efficacy and protection of azelaprag—with and devoid of Eli Lilly’s blockbuster incretin procedure tirzepatide—in greater than two hundred people today with obesity.That's naively, indefinite docking o